Literature DB >> 21308501

The next era of HCV antiviral therapy finally begins: part 1.

David Bobak1.   

Abstract

Entities:  

Year:  2010        PMID： 21308501     DOI： 10.1007/s11908-010-0093-4

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN： 1523-3847            Impact factor:   3.663


× No keyword cloud information.
  11 in total

Review 1.  Hepatitis C virus infection.

Authors:  G M Lauer; B D Walker
Journal:  N Engl J Med       Date:  2001-07-05       Impact factor: 91.245

2.  A step forward in therapy for hepatitis C.

Authors:  Jay H Hoofnagle
Journal:  N Engl J Med       Date:  2009-04-30       Impact factor: 91.245

Review 3.  New and experimental therapies for HCV.

Authors:  Arema A Pereira; Ira M Jacobson
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-07       Impact factor: 46.802

Review 4.  The efficacy and safety of telaprevir - a new protease inhibitor against hepatitis C virus.

Authors:  Ivan Gentile; Maria Aurora Carleo; Federico Borgia; Giuseppe Castaldo; Guglielmo Borgia
Journal:  Expert Opin Investig Drugs       Date:  2010-01       Impact factor: 6.206

Review 5.  Telaprevir: hope on the horizon, getting closer.

Authors:  Ilan S Weisberg; Ira M Jacobson
Journal:  Clin Liver Dis       Date:  2009-08       Impact factor: 6.126

Review 6.  Hepatitis C: recent successes and continuing challenges in the development of improved treatment modalities.

Authors:  Tetsuro Shimakami; Robert E Lanford; Stanley M Lemon
Journal:  Curr Opin Pharmacol       Date:  2009-09-15       Impact factor: 5.547

7.  Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection.

Authors:  John G McHutchison; Gregory T Everson; Stuart C Gordon; Ira M Jacobson; Mark Sulkowski; Robert Kauffman; Lindsay McNair; John Alam; Andrew J Muir
Journal:  N Engl J Med       Date:  2009-04-30       Impact factor: 91.245

8.  Telaprevir and peginterferon with or without ribavirin for chronic HCV infection.

Authors:  Christophe Hézode; Nicole Forestier; Geoffrey Dusheiko; Peter Ferenci; Stanislas Pol; Tobias Goeser; Jean-Pierre Bronowicki; Marc Bourlière; Shahin Gharakhanian; Leif Bengtsson; Lindsay McNair; Shelley George; Tara Kieffer; Ann Kwong; Robert S Kauffman; John Alam; Jean-Michel Pawlotsky; Stefan Zeuzem
Journal:  N Engl J Med       Date:  2009-04-30       Impact factor: 91.245

Review 9.  NIH Consensus Statement on Management of Hepatitis C: 2002.

Authors: 
Journal:  NIH Consens State Sci Statements       Date:  2002 Jun 10-12

Review 10.  Viral hepatitis C.

Authors:  Thierry Poynard; Man-Fung Yuen; Vlad Ratziu; Ching Lung Lai
Journal:  Lancet       Date:  2003-12-20       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.